Literature DB >> 10699919

Human papillomavirus infection and invasive cervical cancer in Paraguay.

P A Rolón1, J S Smith, N Muñoz, S J Klug, R Herrero, X Bosch, F Llamosas, C J Meijer, J M Walboomers.   

Abstract

HPV types 16 and 18 have been categorized as human carcinogens based on their strong associations with cervical cancer in previous case-control studies. Recent IARC studies in the Philippines, Thailand and Morocco show strong associations between invasive cervical cancer and less common HPV types, including HPV 31, 33, 45, 51, 52 and 58. We present results of a further IARC case-control study conducted in Asunción, Paraguay, to examine the association between specific HPV types and invasive cervical cancer as well as risk factors other than HPV. One-hundred thirteen incident histologically confirmed invasive cervical cancer cases and 91 age-matched hospital controls were recruited. A standardized questionnaire was administered to investigate known and suspected risk factors for cervical cancer. For HPV status determination, cervical biopsy specimens from case subjects and exfoliated cervical cells from control subjects were obtained. HPV DNA was ascertained using a GP5+/6+ PCR-based assay capable of detecting more than 33 HPV types. Overall HPV prevalence was 97% in the cervical cancer cases and 20% in the control subjects. As a single infection, HPV 16 was the predominant type with a prevalence of 48% among case subjects and 5.5% among control subjects. Significant associations with the risk of cervical cancer were detected as follows: any HPV type (OR = 114; 95% CI: 36-361); HPV 16 (OR = 910); HPV 18 (infinite OR); HPV 31 (OR = 110); HPV 33 (OR = 261); HPV 45 (OR = 129); and HPV 58 (OR = 36). In the multivariate model, risk factors other than HPV significantly associated with cervical cancer risk were a higher number of lifetime sexual partners, lower educational status and never having had a Pap smear. Strong associations were found between invasive cervical cancer and specific HPV types 16, 18, 31, 33, 45 and 58. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699919

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Variants of human papillomavirus types 53, 58 and 66 identified in Central Brazil.

Authors:  Daniela Marreco Cerqueira; Geni Noceti de Lima Camara; Márcio Rojas da Cruz; Evandro Oliveira Silva; Marcelo de Macelo Brígido; Luciano Gonçalves de Souza Carvalho; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; G Gilkison; M J Arends; C Graham; E McGoogan
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

4.  Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.

Authors:  M Molano; E Weiderpass; H Posso; S A Morré; M Ronderos; S Franceschi; A Arslan; C J L M Meijer; N Muñoz; A J C van den Brule
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

5.  Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic.

Authors:  Petroula Stamataki; Athanasia Papazafiropoulou; Ioannis Elefsiniotis; Margarita Giannakopoulou; Hero Brokalaki; Eleni Apostolopoulou; Pavlos Sarafis; George Saroglou
Journal:  BMC Infect Dis       Date:  2010-02-15       Impact factor: 3.090

6.  Oral and genital HPV genotypic concordance between sexual partners.

Authors:  Camila Maria Beder Ribeiro; Iracema Ferrer; Andreza Barkokebas Santos de Farias; Débora Diniz Fonseca; Igor Henrique Morais Silva; Luiz Alcino Monteiro Gueiros; Alessandra Tavares Carvalho; Stephen Ross Porter; Jair Carneiro Leao
Journal:  Clin Oral Investig       Date:  2013-03-14       Impact factor: 3.573

7.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; A L Seagar; M J Arends; C Moore; G Gilkisson; E McGoogan
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

8.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

9.  Human papillomavirus infection in Honduran women with normal cytology.

Authors:  N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal:  Cancer Causes Control       Date:  2009-08-15       Impact factor: 2.506

10.  HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country.

Authors:  Raúl Murillo; Mónica Molano; Gilberto Martínez; Juan-Carlos Mejía; Oscar Gamboa
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.